Research & Development

伊人2014av手机天堂网免费超在线观看新世界百货中国:原首席执行官何国良辞职 张辉热接任


  夏天的竹筍確實沒什麼吃頭,不過,在山野間,也只好將就了。   萬萬沒想到,衛皇後,母親,以及劉據他們會走的這麼遠,如果霍光所說的事情都是真的,那麼,在母親跟衛皇後的幫助下,漢中,這片劉邦賴以起家的地方,已經成了劉據個人的帝國。伊人   霍去病揮揮手,清掃一下鼻端的白灰,對雲瑯道︰“這該用了多少石灰啊。”2014av手机天堂网免费   “我長壽了,匈奴部族就會短命是吧?” 超在线观看 的大漢志士。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo